Back to search
Cell- and Tissue-Based Therapy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cell- and Tissue-Based Therapy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cell- and Tissue-Based Therapy trials you may qualify forBackground: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune syste…
This phase II trial studies how well a cancer vaccine called STEMVAC works in combination with chemotherapy in treating patients with PD-L1 negative, triple-neg…
This phase I double-blind study focuses on the safety and feasibility of implanting autologous peripheral nerve tissue (PNT) into the substantia nigra area of t…
This clinical trial tests how well a digital treatment platform using a mobile application works for the delivery of home-based sequential therapy in patients w…
This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients…
The purpose of this study is to assess rate of disease relapse and hazard rate of disease relapse after neoadjuvant therapy based on the statuses of pathologic…
Background: Drugs or cell therapies to treat cancer can sometimes cause cytokine release syndrome (CRS). That is, the body makes too many cytokines after treat…
This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma.…